Induction of apoptosis and inhibition of proliferation in human tumor cells treated with extracts of Uncaria tomentosa

Anticancer Research

Volumn 18, Issue 5 A, 1998, Pages 3363-3368

  Sheng, Yezhou ^a   Pero, Ronald W ^a   Amiri, Amir ^a   Bryngelsson, Carl ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Apoptosis; Clonogenic growth; DNA strand breaks; Proliferation; Uncaria tomentosa

Indexed keywords

C MED 100; DNA FRAGMENT; PLANT EXTRACT; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRAIN HL 60; CELL STRAIN K 562; CLONOGENIC ASSAY; DNA STRAND BREAKAGE; DOSE RESPONSE; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RAJI CELL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; HL-60 CELLS; HUMANS; K562 CELLS; PLANT EXTRACTS; PLANTS, MEDICINAL; SOUTH AMERICA; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0031790342     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Keplinger K: Cytostatic, contraceptive and antiinflammatory agents from Uncaria tomentosa. PCT Int Appl., WO 8201, 130, 1982.
2. Wagner H, Kreutzkamp B, Jurcic K: The alkaloids of Uncaria tomentosa and their phagocytosis-stimulating action. Planta Med. Oct(5): 419-23, 1985.
3. Cerri R, Aquino R, De Simone F, Pizza C: New quinovic acid glycosides from Uncaria tomentosa. J Nat Prod 51: 257-261, 1988.
4. Aquino R, De Simone F, Pizza C, Conti C, Stain ML: Plant metabolites. Structure and in vitro antiviral activity of quinovic acid glycosides from Uncaria tomentosa and Guettarda platypoda. J Nat Prod 52(4): 679-85, 1989.
5. Aquino R, De Feo V, De Simone F, Pizza C, Cirino G. Plant metabolites. New compounds and anti-inflammatoiy activity of Uncaria tomentosa. J Nat Prod 54(2): 453-9, 1991.
6. Rizzi R, Re F, Bianchi A, De Feo V, de Simone F, Bianchi L, Stivala LA: Mutagenic and antimutagenic activities of Uncaria tomentosa and its extracts. J Ethnopharmacol 38(1): 63-77, 1993.
7. Cragg GM et al: Role of plants in the National Cancer Institute Drug Discovery and Development Program. In: Human Medicinal Agents from Plants, ACS Symposium Series 534 (eds. Kinghorn AD & Balandrin MF) 80-95, American Chemical Society Books, Wahington, DC, 1993.
8. Wall ME and Wani MC: Camptothecin and analogues: Synthesis, biological in vitro and in vivo activities and clinical possibilities. In: Human Medicinal Agents from Plants, ACS Symposium Series 534 (eds. Kinghorn AD and Balandrin MF) 149-169, American Chemical Society Books, Wahington, DC, 1993.
9. Pisha E, Chai H, Lee IS, et al: Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nature Medicine 1(10): 1046-1051, 1995
10. Dark GG, Hill SA, Prise VE, Tozer GM, Pettit GR and Chaplin DJ: Combredtastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature. Cancer Research 57: 1829-1834, 1997.
11. Rodford IR, Murphy TK, Radley JM and Ellis SL: Radiation response of mouse lymphoid and myeloid cell lines. Part II. Apoptotic death is shown by all lines examined. Int J Radiat Biol 65: 217-227, 1994.
12. D'Amico AV, McKenna WG: Apoptosis and a re-investigation of the biologic basis for cancer therapy. Radiother and Oncol 33: 3-10, 1994.
13. Kaufman SH, Desnoyers S, Ottaviano Y, Davidson NE and Poirier GG. Specific proteilytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Research 53: 3976-3985, 1993.
14. Shih SC, Stutman O: Cell cycle-dependent tumor necrosis factor apoptosis. Cancer Research 56: 1591-1598, 1996.
15. Gibb RK, Taylor DD, Wan T, O'Connor DM, Doering DL, Gercel-Taylor C: Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines. Gynecol Oncol 65(1): 13-22, 1997
16. Pero RW, Olsson A, Simanaitis M, Amiri A and Andersen I: Pharmacokinetics, toxicity, side effects, receptor affinities and in vitro radiosensitizing effects of the novel metochlopramide formulations, Sensamide™ and Neu-Sensamide™. Pharm Toxicol 80: 231-239, 1997.
17. Fisher DA: Apoptosis in cancer therapy: Crossing the threshold. Cell 78: 539-647, 1996.
18. Workman P: Cell proliferation, cell cycle and apoptosis targets for cancer drug discovery: strategies, strengths and pitfalls. In: Apoptosis and cell cycle control in cancer (N.S.B. Thomas, ed.) BIOS Scientific Publishers Ltd, Oxford, pp. 205-232, 1996.
19. Schweitzer CM, van de Loosdrecht AA, Jonkhoff AR, Ossenkoppele GJ, Huijgens PC, Dräger AM, Broekhoven MG, Langenhuijsen MMAC: Spectrophotometric determination of clonogenic capacity of leukemic cells in a semisolid microtiter culture system. Experimental Hematology 21: 573-578, 1993.
20. Matzinger P: The JAM test: A simple assay for DNA fragmentation and cell death. J Immuno Method 145: 185-192, 1991
21. Rokhlin OW, Bishop GA, Hostager BS, Waldschmidt TJ, Sidorenko SP, Pavloff N, Kiefer MC, Umansky SR, Glover RA and Cohen MB: Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Research 57: 1758-1768, 1997.
22. Gupta N, Lamborn K and Deen DF: A statistical approach for analyzing clonogenic survival data. Radiat Res 145: 636-640, 1996
23. Kohn KW, Regina AGE, Leonard CE et al: Measurement of strand breaks and cross-links by alkaline elution. In: Friedberg EC and Hanawalt PC (eds), DNA repair, a laboratory manual of research procedures. Pp379-400, 1981.
24. Cesarone CF, Bolognesi C, Santi L: Improved microfluorometric DNA determination in biological material using 33258 Hoechst. Anal Biochem. Nov 15; 100(1): 188-97, 1979.
25. Hall EJ: Radiobiology for the radiologist, 4th ed. J.B. Lippincott, Philadelphia, 1994.
26. Stupper H, Sturm S, Geisen G, Zillian U and Konwalinka G: A differential sensitivity of Oxindole alkaloids to normal and leukemic cell lines. Planta Medica, 59 Supplement Issue, 1993.
27. Ritke MK, Rusnak JM, Lazo JS, Allan WP, Dive C, Heer S, Yalowich JC: Differential induction of etoposide-mediated apoptosis in human leukemia HL60 and K562 cells. Molecular Pharmacology, 46: 605-611, 1994.
28. Chen M, Quintans J, Fuks Z, Thompson C, Kufe DW and Weichselbaum: Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor a and ceramide. Cancer Research 55: 991-994, 1995
29. Dou QP, An B and Will PL: Induction of a retinoblastoma phosphatase activity by anticancer drugs accomanies p53-independent G1 arrest and apoptosis. Biochemistry 92: 9019-23, 1995
30. McGowan AJ, Ruiz RMC, Gorman AM, Lopez RA and Cotter TG: Reactive oxygen intermediates(s) (ROI): common mediator(s) of poly(ADP-ribose)polymerase (PARP) cleavage and apoptosis. FEBS-Lett. 392(3): 299-303, 1996.
31. MaGahon A, Bissonnette R, Schmitt A, Cotter KM, Green DR and Cotter TG: BCRABL Maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood 83(5): 1179-87, 1994.
32. Wyllie AH: Death from inside out: an overview. Phil Trans R Soc Lond B 345: 237-241, 1994.
33. Earnshaw WC: Nuclear changes in apoptosis. Curr Opinion in Cell Biol 7: 337-343, 1995.
34. Cantoni O, Sestili P, Guidarelli A, Palomba L, Brambilla L and Cattabeni F: Cytotoxic impact of DNA single vs double strand breaks in oxidatively injured cells. Arch Toxicol Suppl 18: 223-35, 1996
35. Peitsch MC, Muller C, and Tschopp J: DNA fragmentation during apoptosis is caused by frequent single-strand cuts. Nucleic Acids Res. 21(18): 4206-9, 1993.